JOHNSON INVESTMENT COUNSEL INC - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 119 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2015. The put-call ratio across all filers is 4.19 and the average weighting 0.9%.

Quarter-by-quarter ownership
JOHNSON INVESTMENT COUNSEL INC ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q3 2016$265,000
-34.1%
2,400
-13.1%
0.01%
-38.5%
Q2 2016$402,000
+18.9%
2,761
+16.9%
0.01%
+8.3%
Q1 2016$338,000
-7.1%
2,3610.0%0.01%
-7.7%
Q4 2015$364,000
+6.4%
2,361
-1.6%
0.01%0.0%
Q3 2015$342,0002,4000.01%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q3 2015
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 650,089$27,95412.84%
Analyst IMS Investment Management Services Ltd. 13,557$5830.02%
LRI Investments, LLC 2,000$85,7780.01%
Gladius Capital Management LP 761$32,7010.00%
RHUMBLINE ADVISERS 12,625$542,4900.00%
Lindbrook Capital, LLC 142$6,1020.00%
Covestor Ltd 26$10.00%
Red Tortoise LLC 40$1,7190.00%
OSAIC HOLDINGS, INC. 199$8,5510.00%
Parallel Advisors, LLC 19$8160.00%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders